Your browser doesn't support javascript.
loading
Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes.
Ping, Zhen; Chen, Si; Hermans, Sjoerd J F; Kenswil, Keane J G; Feyen, Jacqueline; van Dijk, Claire; Bindels, Eric M J; Mylona, Athina M; Adisty, Niken M; Hoogenboezem, Remco M; Sanders, Mathijs A; Cremers, Eline M P; Lindenbergh-Kortleve, Dicky J; Samsom, Janneke N; van de Loosdrecht, Arjan A; Raaijmakers, Marc H G P.
Affiliation
  • Ping Z; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Chen S; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Hermans SJF; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Kenswil KJG; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Feyen J; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van Dijk C; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Bindels EMJ; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Mylona AM; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Adisty NM; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Hoogenboezem RM; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Sanders MA; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Cremers EMP; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
  • Lindenbergh-Kortleve DJ; Laboratory of Pediatrics, Division of Gastroenterology and Nutrition, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Samsom JN; Laboratory of Pediatrics, Division of Gastroenterology and Nutrition, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van de Loosdrecht AA; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
  • Raaijmakers MHGP; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. m.h.g.raaijmakers@erasmusmc.nl.
Leukemia ; 33(2): 536-541, 2019 02.
Article in En | MEDLINE | ID: mdl-30315231
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Biomarkers, Tumor / NF-kappa B / Inflammation Mediators / Mesenchymal Stem Cells / Hematopoiesis Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2019 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Biomarkers, Tumor / NF-kappa B / Inflammation Mediators / Mesenchymal Stem Cells / Hematopoiesis Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2019 Type: Article Affiliation country: Netherlands